ArticleHemaSphere2021

Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future.

Renaud Heine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.